Pro: Should phosphate binders be used in chronic kidney disease stage 3–4?Opponent's comments
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pro: Should phosphate binders be used in chronic kidney disease stage 3–4?Opponent's comments
Authors
Keywords
-
Journal
NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume -, Issue -, Pages gfv405
Publisher
Oxford University Press (OUP)
Online
2015-12-18
DOI
10.1093/ndt/gfv405
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease
- (2017) Michael E. Seifert et al. AMERICAN JOURNAL OF NEPHROLOGY
- Hyperphosphatemia, Phosphoprotein Phosphatases, and Microparticle Release in Vascular Endothelial Cells
- (2015) N. Abbasian et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effect of dietary phosphate intake on the circadian rhythm of serum phosphate concentrations in chronic kidney disease: a crossover study
- (2014) Joachim H Ix et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Sevelamer Versus Calcium Carbonate in Incident Hemodialysis Patients: Results of an Open-Label 24-Month Randomized Clinical Trial
- (2013) Biagio Di Iorio et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Blood Pressure, Proteinuria, and Phosphate as Risk Factors for Progressive Kidney Disease: A Hypothesis
- (2013) Mario Cozzolino et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Phosphate binders in moderate chronic kidney disease: where do we stand?
- (2013) Antonio Bellasi et al. JOURNAL OF NEPHROLOGY
- Fractional Excretion of Phosphorus Modifies the Association between Fibroblast Growth Factor-23 and Outcomes
- (2013) J. R. Dominguez et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Effects of Sevelamer in Stage 3 CKD
- (2013) C. D. Chue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis
- (2013) Sophie A Jamal et al. LANCET
- Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism
- (2013) Makoto Kuro-o Nature Reviews Nephrology
- Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study
- (2012) B. Di Iorio et al. Clinical Journal of the American Society of Nephrology
- Calcium Deficiency Reduces Circulating Levels of FGF23
- (2012) M. E. Rodriguez-Ortiz et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Effects of Phosphate Binders in Moderate CKD
- (2012) G. A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets
- (2012) David M. Spiegel et al. KIDNEY INTERNATIONAL
- Oral calcium carbonate affects calcium but not phosphorus balance in stage 3–4 chronic kidney disease
- (2012) Kathleen M. Hill et al. KIDNEY INTERNATIONAL
- Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients
- (2012) Biagio R. Di Iorio et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial
- (2011) Mahmut Ilker Yilmaz et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Chronic Kidney Disease Progression and Outcome According to Serum Phosphorus in Mild-to-Moderate Kidney Dysfunction
- (2011) A. Bellasi et al. Clinical Journal of the American Society of Nephrology
- Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy
- (2011) L. De Nicola et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition
- (2011) C. Zoccali et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Serum Phosphate and Mortality in Patients with Chronic Kidney Disease
- (2010) H. Eddington et al. Clinical Journal of the American Society of Nephrology
- Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA
- (2009) J. H. Ix et al. Clinical Journal of the American Society of Nephrology
- Investigation of Gender Heterogeneity in the Associations of Serum Phosphorus With Incident Coronary Artery Disease and All-Cause Mortality
- (2008) S. J. Onufrak et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Phosphorus levels are associated with subclinical atherosclerosis in the general population
- (2008) Stephen J. Onufrak et al. ATHEROSCLEROSIS
- Timing of Onset of CKD-Related Metabolic Complications
- (2008) O. Moranne et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease
- (2008) C.P. Kovesdy et al. KIDNEY INTERNATIONAL
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started